Even though the medical relevance with the aforementioned cardiovascular threat factor alterations by tirzepatide is going to be assessed during the planned cardiovascular final result study SURPASS-CVOT ( "form":"scientific-demo","attrs": "text":"NCT04255433","term_id":"NCT04255433" NCT04255433), a pre-specified cardiovascular meta-Examination ind… Read More